431 related articles for article (PubMed ID: 15489218)
21. Astrocytes and mitochondria from adrenoleukodystrophy protein (ABCD1)-deficient mice reveal that the adrenoleukodystrophy-associated very long-chain fatty acids target several cellular energy-dependent functions.
Kruska N; Schönfeld P; Pujol A; Reiser G
Biochim Biophys Acta; 2015 May; 1852(5):925-36. PubMed ID: 25583114
[TBL] [Abstract][Full Text] [Related]
22. Gene redundancy and pharmacological gene therapy: implications for X-linked adrenoleukodystrophy.
Kemp S; Wei HM; Lu JF; Braiterman LT; McGuinness MC; Moser AB; Watkins PA; Smith KD
Nat Med; 1998 Nov; 4(11):1261-8. PubMed ID: 9809549
[TBL] [Abstract][Full Text] [Related]
23. Functional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy.
Schlüter A; Espinosa L; Fourcade S; Galino J; López E; Ilieva E; Morató L; Asheuer M; Cook T; McLaren A; Reid J; Kelly F; Bates S; Aubourg P; Galea E; Pujol A
Hum Mol Genet; 2012 Mar; 21(5):1062-77. PubMed ID: 22095690
[TBL] [Abstract][Full Text] [Related]
24. Phenylbutyrate up-regulates the adrenoleukodystrophy-related gene as a nonclassical peroxisome proliferator.
Gondcaille C; Depreter M; Fourcade S; Lecca MR; Leclercq S; Martin PG; Pineau T; Cadepond F; ElEtr M; Bertrand N; Beley A; Duclos S; De Craemer D; Roels F; Savary S; Bugaut M
J Cell Biol; 2005 Apr; 169(1):93-104. PubMed ID: 15809314
[TBL] [Abstract][Full Text] [Related]
25. Abcd2 is a strong modifier of the metabolic impairments in peritoneal macrophages of ABCD1-deficient mice.
Muneer Z; Wiesinger C; Voigtländer T; Werner HB; Berger J; Forss-Petter S
PLoS One; 2014; 9(9):e108655. PubMed ID: 25255441
[TBL] [Abstract][Full Text] [Related]
26. Pathophysiology of X-linked adrenoleukodystrophy.
Berger J; Forss-Petter S; Eichler FS
Biochimie; 2014 Mar; 98(100):135-42. PubMed ID: 24316281
[TBL] [Abstract][Full Text] [Related]
27. X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism is severely impaired in monocytes but not in lymphocytes.
Weber FD; Wiesinger C; Forss-Petter S; Regelsberger G; Einwich A; Weber WH; Köhler W; Stockinger H; Berger J
Hum Mol Genet; 2014 May; 23(10):2542-50. PubMed ID: 24363066
[TBL] [Abstract][Full Text] [Related]
28. Full length cDNA cloning, promoter sequence, and genomic organization of the human adrenoleukodystrophy related (ALDR) gene functionally redundant to the gene responsible for X-linked adrenoleukodystrophy.
Holzinger A; Mayerhofer P; Berger J; Lichtner P; Kammerer S; Roscher AA
Biochem Biophys Res Commun; 1999 May; 258(2):436-42. PubMed ID: 10329405
[TBL] [Abstract][Full Text] [Related]
29. A novel mutation in the ABCD1 gene of a Moroccan patient with X-linked adrenoleukodystrophy: case report.
Karkar A; Barakat A; Bakhchane A; Fettah H; Slassi I; Dorboz I; Boespflug-Tanguy O; Nadifi S
BMC Neurol; 2015 Nov; 15():244. PubMed ID: 26607867
[TBL] [Abstract][Full Text] [Related]
30. A zebrafish model of X-linked adrenoleukodystrophy recapitulates key disease features and demonstrates a developmental requirement for abcd1 in oligodendrocyte patterning and myelination.
Strachan LR; Stevenson TJ; Freshner B; Keefe MD; Miranda Bowles D; Bonkowsky JL
Hum Mol Genet; 2017 Sep; 26(18):3600-3614. PubMed ID: 28911205
[TBL] [Abstract][Full Text] [Related]
31. The role of peroxisomal ABC transporters in the mouse adrenal gland: the loss of Abcd2 (ALDR), Not Abcd1 (ALD), causes oxidative damage.
Lu JF; Barron-Casella E; Deering R; Heinzer AK; Moser AB; deMesy Bentley KL; Wand GS; C McGuinness M; Pei Z; Watkins PA; Pujol A; Smith KD; Powers JM
Lab Invest; 2007 Mar; 87(3):261-72. PubMed ID: 17260006
[TBL] [Abstract][Full Text] [Related]
32. ABCD1 and X-linked adrenoleukodystrophy: A disease with a markedly variable phenotype showing conserved neurobiology in animal models.
Manor J; Chung H; Bhagwat PK; Wangler MF
J Neurosci Res; 2021 Dec; 99(12):3170-3181. PubMed ID: 34716609
[TBL] [Abstract][Full Text] [Related]
33. ABCD2 is a direct target of β-catenin and TCF-4: implications for X-linked adrenoleukodystrophy therapy.
Park CY; Kim HS; Jang J; Lee H; Lee JS; Yoo JE; Lee DR; Kim DW
PLoS One; 2013; 8(2):e56242. PubMed ID: 23437103
[TBL] [Abstract][Full Text] [Related]
34. Targeted Brain Delivery of Dendrimer-4-Phenylbutyrate Ameliorates Neurological Deficits in a Long-Term ABCD1-Deficient Mouse Model of X-Linked Adrenoleukodystrophy.
Nemeth CL; Gӧk Ö; Tomlinson SN; Sharma A; Moser AB; Kannan S; Kannan RM; Fatemi A
Neurotherapeutics; 2023 Jan; 20(1):272-283. PubMed ID: 36207570
[TBL] [Abstract][Full Text] [Related]
35. X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects.
Berger J; Gärtner J
Biochim Biophys Acta; 2006 Dec; 1763(12):1721-32. PubMed ID: 16949688
[TBL] [Abstract][Full Text] [Related]
36. X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment.
Kemp S; Wanders RJ
Mol Genet Metab; 2007 Mar; 90(3):268-76. PubMed ID: 17092750
[TBL] [Abstract][Full Text] [Related]
37. Adult-onset cerebello-brainstem dominant form of X-linked adrenoleukodystrophy presenting as multiple system atrophy: case report and literature review.
Ogaki K; Koga S; Aoki N; Lin W; Suzuki K; Ross OA; Dickson DW
Neuropathology; 2016 Feb; 36(1):64-76. PubMed ID: 26227820
[TBL] [Abstract][Full Text] [Related]
38. X-linked adrenoleukodystrophy mice demonstrate abnormalities in cholesterol metabolism.
Weinhofer I; Forss-Petter S; Kunze M; Zigman M; Berger J
FEBS Lett; 2005 Oct; 579(25):5512-6. PubMed ID: 16213491
[TBL] [Abstract][Full Text] [Related]
39. X-linked adrenoleukodystrophy: role of very long-chain acyl-CoA synthetases.
Jia Z; Pei Z; Li Y; Wei L; Smith KD; Watkins PA
Mol Genet Metab; 2004; 83(1-2):117-27. PubMed ID: 15464426
[TBL] [Abstract][Full Text] [Related]
40. Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophy.
Asheuer M; Bieche I; Laurendeau I; Moser A; Hainque B; Vidaud M; Aubourg P
Hum Mol Genet; 2005 May; 14(10):1293-303. PubMed ID: 15800013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
